APM News and Press, Aptorum Group Limited From 04/29/22

Aptorum Group press release (NASDAQ:APM): FY GAAP EPS of -$0.71. Revenue of $1.54M (+69.2% Y/Y). For further details see: Aptorum Group GAAP EPS of -$0.71, revenue of $1.54M

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “We”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announ...

Gainers: SQZ Biotechnologies (SQZ) +20%. Amedisys (AMED) +7%. Thermo Fisher Scientific (TMO) +7%. Vascular Biogenics (VBLT) +5%. Opiant Pharmaceuticals (OPNT) +4%. Losers: Teladoc Health (TDOC) -46%. Align Technology (ALGN) -23%. Aptorum Group (APM) -19...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office (“US PTO”) has granted the p...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today announced that an inte...

Gainers: ORIC Pharmaceuticals (ORIC) +19%. Aptorum (APM) +16%. STAAR Surgical (STAA) +16%. Creative Medical Technology (CELZ) +13%. Tempest Therapeutics (TPST) +11%. Losers: NeuroOne Medical Technologies (NMTC) -48%. Clever Leaves (CLVR) -26%. Capricor ...

Gainers: Brookdale Senior Living BKD +16%. American Shared Hospital Services AMS +12%. ImmunityBio IBRX +12%. I-Mab (NASDAQ:IMAB) +11%. Corvus Pharmaceuticals (NASDAQ:CRVS) +9%. Losers: Larimar Therapeutics LRMR -65%. Omnicell (NASDAQ:OMCL) -18%. M...

Aptorum Group is advancing therapeutic programs to serve unmet needs in orphan oncology diseases, infectious diseases, metabolic diseases, women's health and other areas. The company completed Phase 1 clinical trials for its two lead candidates ALS-4 and SACT-1. The company also l...

The big story in the stock market today: Facebook Meta stock . Shares of the tech company fell to levels not seen since the summer of 2020. Even with the pullback in broader markets, Meta Platforms ( NASDAQ:FB ) struggled to reclaim early 2022 prices as uncertainty arose thanks ...

Gainers: BioCardia (NASDAQ:BCDA) +30%. Aptorum Group (NASDAQ:APM) +22%. Bon Natural Life (NASDAQ:BON) +17%. Lightning eMotors (NYSE:ZEV) +15%. Modine Manufacturing (NYSE:MOD) +14%. Battalion Oil (NYSE:BATL) +13%. DXC Technology (NYSE:DXC) +12%. Redwire (NYSE:RDW) +11%. T-Mobile US (NASDAQ:TMU...